Bayer AG (Bayer AG) Net Margin %

: 11.27% (As of Dec. 2023)

View and export this data going back to 2007. Start your Free Trial

Net margin is calculated as Net Income divided by its Revenue. Bayer AG's Net Income for the three months ended in Dec. 2023 was $1,458 Mil. Bayer AG's Revenue for the three months ended in Dec. 2023 was $12,936 Mil. Therefore, Bayer AG's net margin for the quarter that ended in Dec. 2023 was 11.27%.

The historical rank and industry rank for Bayer AG's Net Margin % or its related term are showing as below:

BAYRY' s Net Margin % Range Over the Past 10 Years
Min: -25.35 Med: 8.24 Max: 20.95
Current: -6.17

BAYRY's Net Margin % is ranked worse than
66.5% of 1021 companies
in the Drug Manufacturers industry
Industry Median: 3.7 vs BAYRY: -6.17

Bayer AG Net Margin % Historical Data

The historical data trend for Bayer AG's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bayer AG Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Net Margin %

9.39

-25.35

2.27

8.18

-6.17

Bayer AG Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Net Margin %																5.09	15.14	-17.09	-44.18	11.27

Competitive Comparison

For the Drug Manufacturers - General subindustry, Bayer AG's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bayer AG Net Margin % Distribution

For the Drug Manufacturers industry and Healthcare sector, Bayer AG's Net Margin % distribution charts can be found below:

* The bar in red indicates where Bayer AG's Net Margin % falls into.

Bayer AG Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Bayer AG's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as

Net Margin	=	Net Income (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-3207.197	/	51948.746
	=	-6.17 %

Bayer AG's Net Margin for the quarter that ended in Dec. 2023 is calculated as

Net Margin	=	Net Income (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	1458.015	/	12935.66
	=	11.27 %

Bayer AG (OTCPK:BAYRY) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Bayer AG Net Margin % Related Terms

Thank you for viewing the detailed overview of Bayer AG's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Bayer AG (Bayer AG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bayer AG (OTCPK:BAYRY) » Definitions » Net Margin %

Comparable Companies

Traded in Other Exchanges

BAYZF:USA BAYN:Romania BAY:Poland BAYN:Mexico BAY:Italy BAYER:Hungary 0P6S:UK BAYNd:UK BAYN:Germany BAYN:Austria

Address

Kaiser-Wilhelm-Allee 1, Leverkusen, NW, DEU, 51368

Website

https://www.bayer.com

Bayer is a German healthcare and agriculture conglomerate. Healthcare provides close to half of the company's sales and includes pharmaceutical drugs as well as vitamins and other consumer healthcare products. The firm also has a crop science business that includes seeds, pesticides, herbicides, and fungicides, which was expanded through the acquisition of Monsanto.